- Community driven business intelligence's Logo
No tags found
Companies
No companies found
Advanced Search
Newsfeed
Alerts
Saved Lists
Owler - Community driven business intelligence's Logo
WuXi AppTec
834 Followers on Owler

WuXi AppTec

is a China-based technology platform that offers services such as analytical, process development, and clinical research for pharmaceutical and biotech industries...
Read more
OverviewCompetitorsAcquisitionsFundingInvestmentsNews & Insights

WuXi AppTec

is a China-based technology platform that offers services such as analytical, process development, and clinical research for pharmaceutical and biotech industries...
Read more
WuXi AppTec Chairman & CEO: Ge Li

Chairman & CEO

Ge Li

CEO Approval Rating

83/100

2000

ShanghaiShanghai Municipality

PublicShanghai Stock Exchange2359

Pharmaceuticals & Biotechnology
Medical Research & Laboratories
28348731 NAICS listing

https://www.wuxiapptec.com/

Annual Revenue
$6.1B
Employees
39,414
Funding
$2.6B
Acquisitions
10
Investments
27

News

investment
Dec 08, 2025
https://www.prnewswire.com/news-releases/d3-bio-secures-108-million-in-series-b-financing-to-advance-global-clinical-programs-302636690.html
WuXi AppTec Co., Ltd. has invested $108M in D3 Bio, Inc.
ESG
Sep 08, 2025
PR Newswire
WuXi AppTec Awarded Gold Medal by EcoVadis Sustainability Rating for Second Consecutive Year

WuXi AppTec Competitors

1Covance
2Charles River Laboratories
3Parexel
4Criterium
5Accell Clinical Research
6Genpact
7ICON
8Incyte
9Sartorius
10Illumina
Unlock 17 + competitors

Trending Companies

    ABOUT

  • About Owler
  • Blog

    OFFERINGS

  • Owler Pro
  • Owler API
  • Owler Community

    SUPPORT

  • Support Center
  • Contact Support
  • Talk to Sales

    LEGAL

  • Accessibility
  • Terms & Conditions
  • Privacy

TOP INDUSTRIES

  • Software & Internet
  • Technology
  • Professional Services
  • Retail
  • Computer Companies
  • Health Care Companies
  • Fintech Companies
  • Banking Companies
Owler is now part of Meltwater

© 2026 Owler, Inc.